ReviewJournal for immunotherapy of cancer2021

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy.

James Harber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.